20 June 2020>: Database Analysis
Special AT-rich Sequence Binding-Protein 1 (SATB1) Correlates with Immune Infiltration in Breast, Head and Neck, and Prostate Cancer
Hua Ge 1ABCDEF* , Yan Yan 2BCDE , Maozhao Yan 1CEF , Lingfei Guo 1EF , Kun Mao 1CFDOI: 10.12659/MSM.923208
Med Sci Monit 2020; 26:e923208
Table 4 Correlation analysis between SATB1 and relate genes and markers of immune cells in TIMER.
Description | Gene marker | BRCA | HNSC | PRAD | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
None | Purity | None | Purity | None | Purity | ||||||||
Cor | P | Cor | P | Cor | P | Cor | P | Cor | P | Cor | P | ||
CD8+ T cell | CD8A | 0.231 | *** | 0.114 | *** | 0.276 | *** | 0.248 | *** | 0.127 | ** | 0.047 | 0.339 |
CD8B | 0.222 | *** | 0.117 | *** | 0.300 | *** | 0.267 | *** | 0.012 | 0.781 | −0.039 | 0.430 | |
T cell (general) | CD3D | 0.212 | *** | 0.081 | * | 0.199 | *** | 0.160 | *** | 0.035 | 0.437 | −0.132 | ** |
CD3E | 0.241 | *** | 0.108 | *** | 0.344 | *** | 0.327 | *** | 0.046 | 0.311 | −0.042 | 0.387 | |
CD2 | 0.225 | *** | 0.096 | ** | 0.311 | *** | 0.287 | *** | 0.051 | 0.255 | −0.041 | 0.402 | |
B cell | CD19 | 0.193 | *** | 0.078 | * | 0.330 | *** | 0.312 | *** | −0.003 | 0.942 | −0.178 | *** |
CD79A | 0.234 | *** | 0.108 | *** | 0.386 | *** | 0.375 | *** | 0.017 | 0.713 | −0.046 | 0.352 | |
Monocyte | CD86 | 0.165 | *** | 0.058 | 0.067 | 0.242 | *** | 0.221 | *** | 0.030 | 0.499 | −0.069 | 0.161 |
CD115 (CSF1R) | 0.225 | *** | 0.108 | *** | 0.381 | *** | 0.376 | *** | 0.161 | *** | 0.068 | 0.167 | |
TAM | CCL2 | 0.206 | *** | 0.115 | *** | 0.343 | *** | 0.323 | *** | 0.062 | 0.168 | 0.000 | 0.997 |
CD68 | 0.090 | ** | −0.114 | 0.660 | 0.126 | ** | 0.114 | * | 0.064 | 0.154 | 0.146 | ** | |
IL10 | 0.169 | *** | 0.063 | * | 0.266 | *** | 0.253 | *** | 0.123 | ** | 0.080 | 0.102 | |
M1 Macrophage | INOS (NOS2) | 0.182 | *** | 0.162 | *** | 0.372 | *** | 0.377 | *** | 0.175 | *** | 0.115 | * |
IRF5 | −0.002 | 0.938 | −0.073 | * | 0.104 | * | 0.100 | * | 0.153 | *** | −0.124 | * | |
COX2 (PTGS2) | 0.384 | *** | 0.311 | *** | 0.018 | 0.689 | 0.019 | 0.671 | 0.308 | *** | 0.240 | *** | |
M2 Macrophage | CD163 | 0.156 | *** | 0.068 | * | 0.284 | *** | 0.277 | *** | 0.095 | * | 0.019 | 0.704 |
VSIG4 | 0.132 | *** | 0.041 | 0.198 | 0.269 | *** | 0.261 | *** | 0.004 | 0.373 | 0.047 | 0.337 | |
MS4A4A | 0.186 | *** | 0.070 | * | 0.282 | *** | 0.268 | *** | −0.004 | 0.369 | −0.127 | ** | |
Neutrophils | CD66b (CEACAM8) | 0.076 | * | 0.101 | ** | 0.112 | * | 0.105 | * | 0.027 | 0.541 | 0.023 | 0.636 |
CD11b (ITGAM) | 0.155 | *** | 0.065 | * | 0.445 | *** | 0.428 | *** | 0.212 | *** | 0.127 | ** | |
CCR7 | 0.370 | *** | 0.231 | *** | 0.493 | *** | 0.464 | *** | 0.649 | *** | 0.566 | *** | |
Natural killer cell | KIR2DL1 | 0.384 | *** | 0.315 | *** | 0.248 | *** | 0.242 | *** | −0.033 | 0.463 | −0.083 | 0.092 |
KIR2DL3 | 0.117 | *** | 0.058 | 0.068 | 0.210 | *** | 0.191 | *** | −0.044 | 0.324 | −0.017 | 0.733 | |
KIR2DL4 | 0.133 | *** | 0.061 | 0.056 | 0.115 | ** | 0.119 | ** | 0.084 | 0.061 | 0.084 | 0.087 | |
KIR3DL1 | 0.168 | *** | 0.100 | ** | 0.218 | *** | 0.209 | *** | 0.062 | 0.166 | 0.035 | 0.478 | |
KIR3DL2 | 0.181 | *** | 0.098 | ** | 0.302 | *** | 0.287 | *** | 0.148 | *** | 0.134 | ** | |
KIR3DL3 | 0.101 | *** | 0.065 | * | 0.088 | * | 0.070 | 0.123 | 0.045 | 0.315 | 0.053 | 0.282 | |
KIR2DS4 | 0.149 | *** | 0.086 | ** | 0.115 | ** | 0.101 | * | 0.024 | 0.586 | −0.042 | 0.387 | |
Dendritic cell | HLA-DPB1 | 0.176 | *** | 0.027 | 0.396 | 0.274 | *** | 0.252 | *** | 0.116 | ** | −0.217 | *** |
HLA-DQB1 | 0.142 | *** | 0.039 | 0.217 | 0.193 | *** | 0.166 | *** | 0.033 | 0.466 | −0.106 | * | |
HLA-DRA | 0.199 | *** | 0.072 | * | 0.296 | *** | 0.276 | *** | 0.053 | 0.235 | −0.047 | 0.342 | |
HLA-DPA1 | 0.191 | *** | 0.056 | 0.076 | 0.313 | *** | 0.291 | *** | 0.042 | 0.344 | −0.061 | 0.215 | |
Dendritic cell (cintinued) | BDCA-1(CD1C) | 0.275 | *** | 0.161 | *** | 0.389 | *** | 0.372 | *** | 0.201 | *** | 0.104 | * |
BDCA-4(NRP1) | 0.309 | *** | 0.235 | *** | 0.314 | *** | 0.316 | *** | 0.034 | 0.449 | 0.028 | 0.566 | |
CD11c (ITGAX) | 0.184 | *** | 0.074 | * | 0.336 | *** | 0.330 | *** | −0.024 | 0.599 | −0.065 | 0.187 | |
Th1 | T-bet (TBX21) | 0.230 | *** | 0.109 | *** | 0.267 | *** | 0.237 | *** | −0.009 | 0.849 | −0.064 | 0.190 |
STAT4 | 0.320 | *** | 0.207 | *** | 0.267 | *** | 0.246 | *** | 0.093 | * | 0.021 | 0.674 | |
STAT1 | 0.089 | ** | 0.039 | 0.222 | 0.019 | 0.670 | 0.000 | 0.998 | 0.281 | *** | 0.240 | *** | |
IFN-γ (IFNG) | 0.172 | *** | 0.080 | * | 0.069 | 0.118 | 0.028 | 0.540 | 0.031 | 0.489 | 0.003 | 0.948 | |
TNF-α (TNF) | 0.147 | *** | 0.111 | *** | −0.034 | 0.444 | −0.040 | 0.372 | 0.070 | 0.119 | −0.028 | 0.570 | |
Th2 | GATA3 | −0.308 | *** | −0.251 | *** | 0.202 | *** | 0.182 | *** | 0.196 | *** | 0.115 | * |
STAT6 | 0.022 | 0.468 | −0.023 | 0.478 | 0.100 | ** | 0.105 | * | 0.327 | *** | 0.311 | *** | |
STAT5A | 0.219 | *** | 0.141 | *** | 0.215 | *** | 0.189 | *** | 0.072 | 0.108 | −0.004 | 0.929 | |
IL13 | 0.085 | ** | 0.041 | 0.196 | 0.165 | *** | 0.147 | ** | 0.053 | 0.238 | −0.030 | 0.542 | |
Tfh | BCL6 | 0.081 | 0.069 | 0.053 | 0.096 | 0.341 | *** | 0.356 | *** | 0.131 | ** | 0.137 | ** |
IL21 | 0.150 | *** | 0.083 | ** | 0.335 | *** | 0.300 | *** | 0.015 | 0.731 | 0.017 | 0.732 | |
Th17 | STAT3 | 0.182 | *** | 0.162 | *** | 0.320 | *** | 0.321 | *** | 0.448 | *** | 0.412 | *** |
IL17A | 0.117 | *** | 0.078 | * | 0.151 | *** | 0.131 | ** | 0.148 | *** | 0.033 | 0.504 | |
Treg | FOXP3 | 0.187 | *** | 0.094 | ** | 0.504 | *** | 0.506 | *** | 0.159 | *** | 0.145 | ** |
CCR8 | 0.195 | *** | 0.124 | *** | 0.565 | *** | 0.563 | *** | 0.323 | *** | 0.294 | *** | |
STAT5B | 0.247 | *** | 0.207 | *** | 0.449 | *** | 0.437 | *** | 0.433 | *** | 0.434 | *** | |
TGFβ (TGFB1) | 0.097 | ** | −0.018 | 0.568 | −0.201 | *** | −0.200 | *** | −0.085 | 0.058 | −0.119 | * | |
T cell exhaustion | PD-1 (PDCD1) | 0.164 | *** | 0.041 | 0.194 | 0.236 | *** | 0.212 | *** | 0.054 | 0.232 | 0.100 | * |
CTLA4 | 0.211 | *** | 0.114 | *** | 0.224 | *** | 0.196 | *** | −0.008 | 0.856 | −0.046 | 0.352 | |
LAG3 | 0.062 | * | −0.004 | 0.900 | 0.008 | 0.067 | 0.005 | 0.272 | −0.152 | *** | −0.180 | *** | |
TIM-3 (HAVCR2) | 0.123 | *** | 0.014 | 0.651 | 0.297 | *** | 0.280 | *** | −0.007 | 0.120 | −0.152 | ** | |
GZMB | 0.188 | *** | 0.009 | ** | 0.063 | 0.152 | 0.026 | 0.564 | −0.021 | 0.644 | −0.093 | 0.057 | |
TIMER – Tumor Immune Estimation Resource; BRCA – breast invasive carcinoma; HNSC – head and neck squamous cell carcinoma; PRAD – prostate adenocarcinoma; TAM – tumor-associated macrophages; Th – T helper cell; Tfh – follicular helper T cell; Treg – regulatory T cell; Cor – R value of Spearman’s correlation; None – correlation without adjustment. Purity – correlation adjusted by purity. * ** *** |